Mauro Gibellini, SVP, Corporate Development at Emergent BioSolutions Inc. (EBS), sold 40,900 shares at $9.57 ($397K) on 2007-06-04, disclosed to the SEC on 2007-06-06.
Open-market sale of $397k EBS by SVP, Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 300 | $3K | 0.7% |
| 2 | $9.51 | 1,300 | $12K | 3.1% |
| 3 | $9.52 | 1,000 | $10K | 2.4% |
| 4 | $9.53 | 4,400 | $42K | 10.6% |
| 5 | $9.54 | 500 | $5K | 1.2% |
| 6 | $9.55 | 4,400 |
| $42K |
| 10.6% |
| 7 | $9.56 | 2,400 | $23K | 5.8% |
| 8 | $9.57 | 500 | $5K | 1.2% |
| 9 | $9.58 | 2,900 | $28K | 7.0% |
| 10 | $9.59 | 3,400 | $33K | 8.2% |
| 11 | $9.60 | 1,300 | $12K | 3.1% |
| 12 | $9.61 | 200 | $2K | 0.5% |
| 13 | $9.62 | 200 | $2K | 0.5% |
| 14 | $9.71 | 200 | $2K | 0.5% |
| 15 | $9.72 | 100 | $972 | 0.2% |
| 16 | $9.75 | 3,400 | $33K | 8.4% |
| 17 | $9.80 | 2,000 | $20K | 4.9% |
| 18 | $9.82 | 800 | $8K | 2.0% |
| 19 | $9.85 | 800 | $8K | 2.0% |
| 20 | $9.86 | 300 | $3K | 0.7% |
| 21 | $9.88 | 1,900 | $19K | 4.7% |
| 22 | $9.90 | 1,700 | $17K | 4.2% |
| 23 | $10.00 | 3,800 | $38K | 9.6% |
| 24 | $10.01 | 1,500 | $15K | 3.8% |
| 25 | $10.02 | 800 | $8K | 2.0% |
| 26 | $10.06 | 200 | $2K | 0.5% |
| 27 | $10.07 | 200 | $2K | 0.5% |
| 28 | $10.08 | 400 | $4K | 1.0% |
| Total | $9.71 avg | 40,900 | $397K | 100% |